scaht logo
SCAHT logo
EN DE FR
Regulatorische Toxikologie
Forschung SCAHT logo
SCAHT Direktorat SCAHT logo
ISTNET-DART
PARC
CHIASMA
ONTOX
Forschungsförderung
Lehre SCAHT logo
SCAHT AOP_HUB
Publikationen
News SCAHT logo
Events
Newsletter
Agency News Corner
Ressourcen SCAHT logo
Links and Tools
Updates zu globalen Richtlinien
Team
ANMELDUNG FÜR DEN NEWSLETTER

Bei Verdacht auf Vergiftung kontaktieren Sie Tox Info Suisse

24h-Notfallnummer Tel 145

(aus dem Ausland: +41 44 251 51 51)

Kontakt Datenschutz & Rechtliche Hinweise
EN DE FR
Regulatorische Toxikologie
Forschung SCAHT logo
SCAHT Direktorat SCAHT logo
ISTNET-DART
PARC
CHIASMA
ONTOX
Forschungsförderung
Lehre SCAHT logo
SCAHT AOP_HUB
Publikationen
News SCAHT logo
Events
Newsletter
Agency News Corner
Ressourcen SCAHT logo
Links and Tools
Updates zu globalen Richtlinien
Team
ANMELDUNG FÜR DEN NEWSLETTER

Bei Verdacht auf Vergiftung kontaktieren Sie Tox Info Suisse

24h-Notfallnummer Tel 145

(aus dem Ausland: +41 44 251 51 51)

Kontakt Datenschutz & Rechtliche Hinweise

16 Nov 2012

Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.

15 Nov 2012

Species-specific differences in the inhibition of human and zebrafish 11β-hydroxysteroid dehydrogenase 2 by thiram and organotins

1 Nov 2012

Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA

17 Okt 2012

Comparison of four drug interaction screening programs

12 Okt 2012

Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action.

1 Okt 2012

Transcriptional regulation of CYP2C19 and its role in altered enzyme activity

19 Sep 2012

Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

21 Aug 2012

Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers.

20 Aug 2012

Analgesics in patients with hepatic impairment: pharmacology and clinical implications

1 Aug 2012

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection

  • «
  • …
  • 42
  • 43
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • 49
  • 50
  • …
  • »
logo scaht
logo université de genève
logo université de lausanne
logo fhnw
SCAHT newsletter subscriptions
* indicates required
Please select at least one newsletter

Please select all the ways you would like to hear from SCAHT - Swiss Centre for Applied Human Toxicology / University of Basel:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.